Next Advance Revenue and Competitors
Estimated Revenue & Valuation
- Next Advance's estimated annual revenue is currently $2.6M per year.
- Next Advance's estimated revenue per employee is $155,000
Employee Data
- Next Advance has 17 Employees.
- Next Advance grew their employee count by -19% last year.
Next Advance's People
Name | Title | Email/Phone |
---|---|---|
1 | President | Reveal Email/Phone |
2 | Sustaining Engineer | Reveal Email/Phone |
3 | Scientist | Reveal Email/Phone |
4 | Web Developer | Reveal Email/Phone |
5 | Production Engineer | Reveal Email/Phone |
Next Advance Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Next Advance?
Next Advance was founded in response to the pressing need for affordable molecular biology instruments that automate mundane tasks, allowing scientists to avoid repetitive, time-consuming procedures. Our products, including homogenizers, automated blot processors, rockers, pumps, and more, are engineered to meet your specific lab requirements and budgets. They enable researchers and scientists to work faster and more cost-effectively, increasing overall productivity and total bench success. ------------------------------------------------------------------------------------------------------
keywords:N/AN/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.2M | 17 | 6% | N/A |
#2 | $2.8M | 17 | -50% | N/A |
#3 | $3.3M | 17 | -19% | N/A |
#4 | $2.1M | 17 | N/A | N/A |
#5 | $2.9M | 18 | 20% | N/A |